Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Implantable Cardioverter Defibrillators (ICDs) Market In 2029?
The market for implantable cardioverter defibrillators (ICDs) has experienced significant growth in recent years. It is projected to increase from a value of $3.76 billion in 2024 to $3.98 billion in 2025, displaying a compound annual growth rate (CAGR) of 5.8%. This growth in the historical period is the result of factors such as the growing frequency of sudden cardiac arrest, the use of implantable cardioverter defibrillators in preventing further instances of sudden cardiac arrest, increasing public awareness, a booming elderly population, supportive government and healthcare organization policies, and improved accessibility to healthcare.
There is an anticipation for robust expansion in the market sector of the implantable cardioverter defibrillators (icds). The market is projected to expand to a worth of$4.95 billion by the year 2029, which reflects a compound annual growth rate (CAGR) of 5.6%. Several aspects contribute to this growth over the forecast period, including an increasing acceptance of implantable defibrillators, a surge in the requirement for more individualized cardiac care, a rising occurrence of cardiac rhythm disorders, and an escalating demand in developing markets. The forecasting period also sees several key trends like technological improvements, the launch of subcutaneous ICD avoiding transvenous leads, the demand for combined ICD devices with pacemaker features, enhancement in sensing and detection algorithms, ongoing progress in wireless charging and battery technology, and the use of artificial intelligence (AI) in healthcare and data analytics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Implantable Cardioverter Defibrillators (ICDs) Market?
The escalating occurrence of cardiovascular diseases (CVDs) is anticipated to foster the expansion of the implantable cardioverter defibrillators (ICDs) marketplace. Cardiovascular diseases (CVDs) refer to a set of disorders impacting the heart and blood vessels, comprising episodes like heart attacks, strokes, and hypertension, often incited by elements such as inadequate diet, sedentary lifestyle, tobacco usage, and genetics. The escalating occurrence of cardiovascular diseases is mainly attributed to aging demographics, detrimental lifestyle preferences, and growing rates of risk variables like obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) aid in managing cardiovascular diseases (CVDs) by delivering crucial electrical jolts to reinstate regular heart rhythms in patients vulnerable to abrupt cardiac arrest. For instance, as stated by the Australian Institute of Health and Welfare, a government agency based in Australia, in December 2023, doctor-verified fatalities owing to coronary heart disease (CHD) escalated to 14,100 in 2021 and further swelled to 14,900 in 2022. Consequently, the escalating occurrence of cardiovascular diseases (CVDs) is propelling the expansion of the implantable cardioverter defibrillators (ICDs) marketplace.
Which Key Market Segments Comprise the Implantable Cardioverter Defibrillators (ICDs) Market and Drive Its Revenue Growth?
The implantable cardioverter defibrillators (icds)market covered in this report is segmented –
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp
Which Areas Are Leading Regions in the Implantable Cardioverter Defibrillators (ICDs) Market Expansion Across the Globe?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theImplantable Cardioverter Defibrillators (ICDs) Market Over the Coming Years?
Leading firms in the implantable cardioverter defibrillators (ICDs) segment are concentrating on technological improvements such as defibrillators with low current consumption to boost efficiency, extend battery lifespan and increase patient comfort. These defibrillators, consuming less energy in delivering electrical shocks to the heart, contribute to life extension of batteries and effective arrhythmia treatment. MicroPort CRM, a medical devices corporation from France launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan in October 2023, marking significant progression in cardiac care technology. These devices come with innovative features like low current consumption for extended battery life and MRI compatibility, making them compatible for patients requiring imaging procedures. The ULYS ICD incorporates the PARAD+ arrhythmia discrimination algorithm and AutoMRI feature, which further ensures patient safety during MRI examinations. Moreover, in clinical trials, the INVICTA lead recorded a 100% success rate for implantation and a 97.4% rate free from complications, underlining its reliability and efficiency.
View the full report here:
How Is the Implantable Cardioverter Defibrillators (ICDs) Market Conceptually Defined?
Implantable cardioverter defibrillators (ICDs) are small devices implanted under the skin, typically near the chest, designed to monitor the heart’s rhythm and deliver electrical shocks if a life-threatening arrhythmia, such as ventricular fibrillation, is detected. Their purpose is to prevent sudden cardiac arrest by restoring a normal heart rhythm.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20839
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model